Markwalder R - Search Results

1

Osteopontin: possible role in prostate cancer progression.

Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, Farach-Carson CM, Studer UE, Chung LW. Thalmann GN, et al. Among authors: markwalder r. Clin Cancer Res. 1999 Aug;5(8):2271-7. Clin Cancer Res. 1999. PMID: 10473115

2

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, Studer UE. Madersbacher S, et al. Among authors: markwalder r. J Clin Oncol. 2003 Feb 15;21(4):690-6. doi: 10.1200/JCO.2003.05.101. J Clin Oncol. 2003. PMID: 12586807

3

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.

Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Fleischmann A, et al. Among authors: markwalder r. J Clin Oncol. 2005 Apr 1;23(10):2358-65. doi: 10.1200/JCO.2005.03.084. J Clin Oncol. 2005. PMID: 15800327

4

Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer.

Rentsch CA, Cecchini MG, Schwaninger R, Germann M, Markwalder R, Heller M, van der Pluijm G, Thalmann GN, Wetterwald A. Rentsch CA, et al. Among authors: markwalder r. Int J Cancer. 2006 Feb 15;118(4):899-906. doi: 10.1002/ijc.21449. Int J Cancer. 2006. PMID: 16106424

5

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.

Prtilo A, Leach FS, Markwalder R, Kappeler A, Burkhard FC, Cecchini MG, Studer UE, Thalmann GN. Prtilo A, et al. Among authors: markwalder r. J Urol. 2005 Nov;174(5):1814-8; discussion 1818. doi: 10.1097/01.ju.0000176796.47988.64. J Urol. 2005. PMID: 16217293

6

Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?

Burkhard FC, Markwalder R, Thalmann GN, Studer UE. Burkhard FC, et al. Among authors: markwalder r. Urol Res. 1997;25 Suppl 1:S31-5. doi: 10.1007/BF00942045. Urol Res. 1997. PMID: 9079754

7

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.

Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK, Studer UE. Mottaz AE, et al. Among authors: markwalder r. Prostate. 1997 Jun 1;31(4):209-15. doi: 10.1002/(sici)1097-0045(19970601)31:4<209::aid-pros1>3.0.co;2-f. Prostate. 1997. PMID: 9180930

8

Is a limited lymph node dissection an adequate staging procedure for prostate cancer?

Bader P, Burkhard FC, Markwalder R, Studer UE. Bader P, et al. Among authors: markwalder r. J Urol. 2002 Aug;168(2):514-8; discussion 518. doi: 10.1016/s0022-5347(05)64670-8. J Urol. 2002. PMID: 12131300

9

Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

Thalmann GN, Markwalder R, Walter B, Studer UE. Thalmann GN, et al. Among authors: markwalder r. J Urol. 2002 Oct;168(4 Pt 1):1381-5. doi: 10.1016/S0022-5347(05)64454-0. J Urol. 2002. PMID: 12352398

10

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Bader P, Burkhard FC, Markwalder R, Studer UE. Bader P, et al. Among authors: markwalder r. J Urol. 2003 Mar;169(3):849-54. doi: 10.1097/01.ju.0000049032.38743.c7. J Urol. 2003. PMID: 12576797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters